Bcl 2 Like Protein 1 (Apoptosis Regulator BclX or BCLX or BCL2L1) — Pipeline Review, H1 2018
Bcl 2 Like Protein 1 Market offers in-depth insights, revenue details, and other vital information regarding the global Bcl 2 Like Protein 1 market and the various trends, drivers, restraints, opportunities, and threats in the target market till 2023. The report also offers insightful and detailed information regarding the various key players operating in the global Bcl 2 Like Protein 1 market, and their financials, apart from strategies, acquisitions & mergers, and market footprint. The global Bcl 2 Like Protein 1 market is being segmented on the basis of product, application, end user, and region.
Bcl 2 Like Protein 1 Apoptosis Regulator BclX or BCLX or BCL2L1 Pipeline Review, H1 2018
Download FREE Sample of this Report @ https://www.24marketreports.com/report-sample/bcl-2-like-protein-1-apoptosis-regulator-bclx-or-bclx-or-bcl2l1pipeline-review-h1-2018-market-12
According to the recently published report Bcl 2 Like Protein 1 Pipeline Review, H1 2018; Bcl 2 Like Protein 1 Apoptosis Regulator BclX or BCLX or BCL2L1 pipeline Target constitutes close to 8 molecules. Out of which approximately 6 molecules are developed by companies and remaining by the universities/institutes.
Bcl 2 Like Protein 1 Apoptosis Regulator BclX or BCLX or BCL2L1 Bcl2like protein 1 is a protein encoded by the BCL2L1 gene. It belongs to BCL2 family. It is a potent inhibitor of cell death. It inhibits activation of caspases. It regulate cell death by blocking the voltagedependent anion channel by binding to it and preventing the release of the caspase activator CYC1 from the mitochondrial membrane. It acts as a regulator of G2 checkpoint and progression to cytokinesis during mitosis.
The report Bcl 2 Like Protein 1 Pipeline Review, H1 2018 outlays comprehensive information on the Bcl 2 Like Protein 1 Apoptosis Regulator BclX or BCLX or BCL2L1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action MoA, route of administration RoA and molecule type; that are being developed by Companies / Universities.
It also reviews key players involved in Bcl 2 Like Protein 1 Apoptosis Regulator BclX or BCLX or BCL2L1 targeted therapeutics development with respective active and dormant or discontinued projects. Currently, The molecules developed by companies in Phase II, Phase I, Preclinical and Discovery stages are 2, 1, 1 and 2 respectively. Similarly, the universities portfolio in Discovery stages comprises 2 molecules, respectively. Report covers products from therapy areas Oncology and Infectious Disease which include indications SmallCell Lung Cancer, Solid Tumor, Chronic Lymphocytic Leukemia CLL, Glioblastoma Multiforme GBM, Hepatocellular Carcinoma, Leukemias, Metastatic Melanoma, MethicillinResistant Staphylococcus aureus MRSA Infections, Myelofibrosis, NonSmall Cell Lung Cancer, PostEssential Thrombocythemia Myelofibrosis PostET MF and PostPolycythemia Vera Myelofibrosis PPVMF.
Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
Scope
The report provides a snapshot of the global therapeutic landscape for Bcl 2 Like Protein 1 Apoptosis Regulator BclX or BCLX or BCL2L1
The report reviews Bcl 2 Like Protein 1 Apoptosis Regulator BclX or BCLX or BCL2L1 targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industryspecific sources
The report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages
The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
The report reviews key players involved in Bcl 2 Like Protein 1 Apoptosis Regulator BclX or BCLX or BCL2L1 targeted therapeutics and enlists all their major and minor projects
The report assesses Bcl 2 Like Protein 1 Apoptosis Regulator BclX or BCLX or BCL2L1 targeted therapeutics based on mechanism of action MoA, route of administration RoA and molecule type
The report summarizes all the dormant and discontinued pipeline projects
The report reviews latest news and deals related to Bcl 2 Like Protein 1 Apoptosis Regulator BclX or BCLX or BCL2L1 targeted therapeutics
Get the Complete Report & TOC @ https://www.24marketreports.com/life-sciences/bcl-2-like-protein-1-apoptosis-regulator-bclx-or-bclx-or-bcl2l1pipeline-review-h1-2018-market-12
Table of content
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Bcl 2 Like Protein 1 Apoptosis Regulator BclX or BCLX or BCL2L1 Overview
Bcl 2 Like Protein 1 Apoptosis Regulator BclX or BCLX or BCL2L1 Therapeutics Development
Products under Development by Stage of Development
Products under Development by Therapy Area
Products under Development by Indication
Products under Development by Companies
Products under Development by Universities/Institutes
Bcl 2 Like Protein 1 Apoptosis Regulator BclX or BCLX or BCL2L1 Therapeutics Assessment
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Bcl 2 Like Protein 1 Apoptosis Regulator BclX or BCLX or BCL2L1 Companies Involved in Therapeutics Development
AbbVie Inc
Ascentage Pharma Group Corp Ltd
Merrimack Pharmaceuticals Inc
Takeda Pharmaceutical Co Ltd
Bcl 2 Like Protein 1 Apoptosis Regulator BclX or BCLX or BCL2L1 Drug Profiles
ABT737 Drug Profile
Product Description
Mechanism Of Action
R&D Progress
APG1252 Drug Profile
Product Description
Mechanism Of Action
R&D Progress
AT101 Drug Profile
Product Description
Mechanism Of Action
R&D Progress
navitoclax dihydrochloride Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule to Inhibit BCL2 and BCLX for Oncology Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Inhibit Mcl1 and BclxL for Oncology Drug Profile
Product Description
If You Have Any Question Related To This Report Contact Us @ https://www.24marketreports.com/enquire-now/bcl-2-like-protein-1-apoptosis-regulator-bclx-or-bclx-or-bcl2l1pipeline-review-h1-2018-market-12
CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170
Fax: (+1) 212 634 4885
Email: [email protected]
Follow Us On linkedin :- https://www.linkedin.com/company/24-market-reports